Other Events ·
Nasdaq notifies Innventure of non-compliance with the $1.00 minimum bid price requirement
INVInnventure, Inc.
Innventure, Inc. received a notice from Nasdaq stating its common stock failed to maintain the required minimum closing bid price of $1.00 for thirty consecutive business days ending October 22, 2026. The company has an initial compliance period until April 21, 2027, to regain compliance by maintaining a bid price above $1.00 for at least ten consecutive business days. Failure to comply may result in delisting from the Nasdaq Global Market or a transfer to the Nasdaq Capital Market if additional listing standards are met. Innventure operates as a biotechnology company focused on developing therapies for rare diseases.